Check out our latest industry white papers. Browse now!
Sales & Support: +1 800 762 3361
Member Resources

The Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos (Institute of Technology in Immunobiology Bio-Manguinhos) in Brazil started, in August, construction of a 200,000-square-meter New Final Processing Center, to host the so-called Cibs (Complexo Industrial de Biotecnologia em Saude, or Industrial Complex of Biotechnology for Health) in Santa Cruz, Rio de Janeiro, Brazil. Once the project is completed in 2023, the facility is expected to produce 120 million vials per year of vaccines for meningitis, hepatitis, and triple bacterial infections.

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

IIR Logo Globe

Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.

×
×

Contact Us

For More Info!